Traitement de la pyélonéphrite chez l'enfant en 2007 [Pyelonephritis treatment in children in 2007: current literature review].

Détails

ID Serval
serval:BIB_5A5CAD06747D
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Traitement de la pyélonéphrite chez l'enfant en 2007 [Pyelonephritis treatment in children in 2007: current literature review].
Périodique
Revue Médicale Suisse
Auteur⸱e⸱s
Cachat F., Zeier G., Parvex P., Girardin E., Von Vigier R., Konrad M., Rudin C., Neuhaus T.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
2007
Volume
3
Numéro
100
Pages
510-514
Langue
français
Notes
Publication types: English Abstract ; Journal Article ; Review Publication Status: ppublish
Résumé
Four studies, including two being published as an abstract, have recently demonstrated the feasibility of oral treatment of pyelonephritis in children, with no increased risk of treatment failure, early urinary tract re-infection, or renal scars. To do so, the pediatrician must ensure that: (1) the patient does not appear toxic, has no vomiting; (2) there is no known severe obstructive or refluxing uropathy and (3) parents are deemed to be adherent to the treatment. If these criteria are fulfilled, the pediatrician can start an oral treatment with a 3rd generation cephalosporine for 10 to 14 days. Ambulatory follow-up is crucial, and persistance of fever after 3 days is a reason for a new outpatient visit, additional or supplementary imaging studies (renal ultrasonography) and eventually a switch to intravenous treatment.
Mots-clé
Administration, Oral, Child, Humans, Injections, Intravenous, Pyelonephritis/drug therapy
Pubmed
Création de la notice
15/01/2008 14:28
Dernière modification de la notice
20/08/2019 14:13
Données d'usage